Author

Elizabeth Bone

Observed names: ELIZABETH A. BONE, Elizabeth A. Bone

Observed institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Churchill Hospital, University of Manchester, Royal Marsden Hospital

OpenAlex ID: A5111844767

A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors

2009 · Alison H.M. Reid, Andrew Protheroe, et al. · Clinical Cancer Research · 35

The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias

2016 · Joanna Zabkiewicz, Marie Gilmour, et al. · Oncotarget · 14

The Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) Shows Selective In Vitro Efficacy In Monocytoid-Lineage Acute Myeloid Leukaemia (AML)

2013 · Joanna Zabkiewicz, Marie Gilmour, et al. · Blood · 1

Role of intracellular pH as a signal in the stimulation of pancreatic islets

1988 · LEONARD BEST, ELIZABETH A. BONE, et al. · Biochemical Society Transactions

Works count: 4

Citation count: 50

H-index: 2

I10-index: 2